BioWorld MedTech

May 21, 2012

EuroPCR 2012: Robust new generation valves fix leaks and flaws

PARIS The wide adoption of transcatheter aortic valve implantation (TAVI) techniques is funding an impressive industrial effort to fix the flaws in first generation devices. Read More

MedTech Investing Conference: 'Elsewhere' seen as alternative locales for financings, trials

Digestive Diseases Week 2012: Med-tech gets to the gut of the matter at DDW

Washington roundup: Report on NIH funding hints at panic over OUS research

Deals roundup: Agilent acquires Dako from EQT for $2.2 billion

People in the News

Financings roundup: SQI closes C$2.3M through second tranche of placement

MDD's Fun Facts

EuroPCR notebook: Boston Scientific reveals 2-year results for PLATINUM study

Agreements/contracts: Sequenom, Coventry Health update participation network

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...